ClinicalTrials.Veeva

Menu

Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement (OSASPI)

M

Marmara University

Status

Completed

Conditions

Scleroderma, Systemic
Sleep Apnea, Obstructive
Pulmonary Disease

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02740569
09.2016.208

Details and patient eligibility

About

Scleroderma is an autoimmune disease with skin manifestations and may have pulmonary involvement. Obstructive sleep apnea (OSA) may also be seen in scleroderma. Less is known regarding the prevalence of OSA in scleroderma and its association with pulmonary involvement.

Full description

Scleroderma is an autoimmune disease with skin manifestations and may have pulmonary involvement. OSA may also be seen in scleroderma. Less is known regarding the prevalence of obstructive sleep apnea in scleroderma and its association with pulmonary involvement.

The investigators would like to address the prevalence of OSA in patients with Scleroderma, using overnight cardiorespiratory polygraphy. Other comorbidities and pulmonary findings on computer tomography (CT) as well as lung function tests will be evaluated.

The investigators plan to include 60 patients.

Enrollment

62 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Known scleroderma diagnosis
  • Must be able to give informed consent

Exclusion criteria

  • Serious neurological and/or psychiatric disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems